Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03109899
Other study ID # 17-22103
Secondary ID 5K23MH104116
Status Recruiting
Phase N/A
First received
Last updated
Start date September 18, 2019
Est. completion date January 2021

Study information

Verified date February 2020
Source Public Health Foundation Enterprises, Inc.
Contact Kenneth Coleman, MA
Phone 628-217-7443
Email kenneth.coleman@sfdph.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The PHASTT Study is focused on understanding of facilitators and barriers to mHealth use among young Black men who have sex with men (MSM), and testing a novel mobile app to increase HIV/STI testing and PrEP uptake.


Description:

The Sex Pro mobile application (app) being tested facilitates home HIV-testing, home sexually transmitted infection (STI) test self-collection, and pre-exposure prophylaxis (PrEP) uptake. The app integrates a personalized HIV risk assessment with home HIV and STI testing options for young, Black MSM.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date January 2021
Est. primary completion date January 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria:

- Self-identify as Black.

- Self-report being HIV negative.

- Report anal sex with at two or more male sex partners in the prior 12 months.

- Own an iOS or Android mobile phone.

- Willing and able to give written informed consent to participate in all activities outlined by the protocol.

Exclusion Criteria:

- Inadequate contact information for follow-up

- In a mutually monogamous sexual relationship for the past 12 months

- Currently taking PrEP

- Does not have reliable access to the internet

- Does not live, work or play in the San Francisco Bay Area

- Currently enrolled in another HIV intervention study

- Prior enrollment in an HIV vaccine trial with receipt of experimental vaccine product

- Any medical, psychiatric, or social condition, or occupational, or other responsibility that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Sex Pro mobile Application
Mobile mHealth app that provides HIV risk assessment, home HIV/STI testing options, and PrEP uptake support for young Black MSM.

Locations

Country Name City State
United States Bridge HIV, San Francisco Department of Public Health San Francisco California

Sponsors (4)

Lead Sponsor Collaborator
Public Health Foundation Enterprises, Inc. National Institute of Mental Health (NIMH), San Francisco Department of Public Health, University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The feasibility and acceptability of Sex Pro to increase HIV/STI testing and PrEP uptake among young Black MSM. As measured via computer assisted interview (CASI) 9 months
Secondary The rate of HIV testing in the Sex Pro mobile application intervention versus control arms. As measured by CASI 9 months
Secondary The rate of STI testing in the Sex Pro mobile application intervention versus control arms. As measured by CASI 9 months
Secondary The rate of PrEP uptake in the Sex Pro mobile application intervention versus control arms. As measured by pharmacy confirmation 9 months
Secondary Changes in sexual risk behaviors among young Black MSM in the Sex Pro mobile application intervention vs. control arms As measured via CASI 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2